| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.98B | 11.55B | 13.17B | 13.26B | 15.56B | 13.77B |
| Gross Profit | 5.26B | 5.08B | 6.56B | 6.76B | 8.71B | 6.16B |
| EBITDA | -470.00M | -504.00M | 1.18B | 773.00M | 2.33B | -170.00M |
| Net Income | -902.00M | -1.01B | 585.00M | -740.00M | 1.02B | -1.33B |
Balance Sheet | ||||||
| Total Assets | 19.65B | 19.26B | 21.39B | 20.48B | 22.14B | 20.36B |
| Cash, Cash Equivalents and Short-Term Investments | 7.23B | 8.31B | 12.70B | 11.24B | 13.25B | 11.11B |
| Total Debt | 391.00M | 13.00M | 26.00M | 60.00M | 110.00M | 176.00M |
| Total Liabilities | 2.96B | 2.40B | 3.08B | 2.68B | 3.33B | 2.41B |
| Stockholders Equity | 16.60B | 16.85B | 18.32B | 17.81B | 18.81B | 17.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.14B | 1.10B | -1.37B | 2.44B | -1.46B |
| Operating Cash Flow | 0.00 | -1.80B | 1.51B | -733.00M | 3.00B | -1.04B |
| Investing Cash Flow | 0.00 | -2.68B | 117.00M | -1.08B | -639.00M | 3.32B |
| Financing Cash Flow | 0.00 | -509.00M | -160.00M | -193.00M | -225.00M | -219.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥8.40B | 8.70 | ― | 2.75% | -4.76% | 8.43% | |
71 Outperform | ¥10.00B | 3.85 | ― | 2.77% | -2.28% | 36.25% | |
65 Neutral | ¥7.30B | 10.30 | ― | ― | 157.12% | ― | |
63 Neutral | ¥4.83B | -8.31 | ― | 2.36% | 2.14% | -0.39% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
48 Neutral | ¥12.45B | 31.04 | ― | 3.35% | -8.02% | -59.42% | |
44 Neutral | ¥5.59B | -0.54 | ― | 2.23% | -0.67% | -453.71% |